Close
Nordic 9Nordic 9

Bioqube Ventures (investor - Venture Capital)

Belgium bioqubeventures.com
See something wrong or missing? Let us know
Offices:Bruxelles

Bioqube Ventures is a specialist life sciences venture capital investor investing in European biotechnology companies

Average round investment:37.53M USD
Average number per year:2.8
Distribution: 2025 (5)2024 (3)2023 (1)2022 (2)2021 (3)
Portfolio companies: United Kingdom Enhanc3DNorway ActitheraBelgium Spica Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (3) Biotech (14)
See the entire list

Showing 3 of 14 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Bioqube Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bioqube Ventures

Name Criteria
France AdBio partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, Belgium, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France Creadev
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium Vives Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Day One Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France Mutuelles Impact
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Belgium VIB
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, Belgium
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
United Kingdom SV Health Investors
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Ireland
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Broadview Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark, Ireland, France
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
France Turenne Capital Partenaires
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United States Paladin Capital Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Germany, Ireland
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Top